CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus

NCT06839976 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

SLE
Systemic Lupus Erythematosus (SLE)
CAR T Cell
CART19
Cell Therapy
Lupus
Lupus Nephritis (LN)

Interventions

BIOLOGICAL: CART19

Sponsor

Children's Hospital of Philadelphia